Read by QxMD icon Read

Clinical Neuropsychologist

Karen Postal, Clifton Chow, Sharon Jung, Kalen Erickson-Moreo, Flannery Geier, Margaret Lanca
OBJECTIVE: Though some neuropsychological groups have proposed criteria and suggestions for clinical report writing there has never been professional consensus or accepted published guidelines on how to write reports. Given the paucity of guidelines and the evolving practice climate, we sought to survey neuropsychologists and referral source stakeholders to understand current report writing practices. METHOD: The data were collected in two SurveyMonkey surveys via professional list servs, email, and LinkedIn clinical interest groups...
September 17, 2017: Clinical Neuropsychologist
Jerry J Sweet, Catherine Lee, Leslie M Guidotti Breting, Laura M Benson
OBJECTIVE: This paper describes gender-related trends within clinical neuropsychology, based primarily on recurrent practice surveys within the specialty and, to a lesser extent, job-related information from medical specialties and the general U.S. labor market. METHOD: Chronological and cross-sectional analyses of professional practice survey data from 2005, 2010, and 2015 relevant to gender. As is common with survey data, descriptive analysis and independent samples t-tests were conducted...
September 5, 2017: Clinical Neuropsychologist
David S Nichols
The 'Commentary' of Drs. Larrabee, Bianchini, Boone, and Rohling (this issue) attributes to us a view of the Fake Bad/Symptom Validity Scale (FBS/FBS-r) that is wholly erroneous, a view we do not hold and have never taken. In doing so, the authors have confused the thrust of our article with the assertions made in an earlier article which preceded publication of the FBS. This earlier article held that many physical and cognitive symptoms/complaints observed in personal injury plaintiffs are most parsimoniously understood as manifestations of the stresses that may routinely accompany plaintiffs' involvement in such litigation...
September 2, 2017: Clinical Neuropsychologist
R Saloner, K B Casaletto, G Marx, S Dutt, A B Vanden Bussche, M You, E Fox, J Stiver, J H Kramer
OBJECTIVE: Traditional episodic memory tests employ a delayed recall length ranging from 10 to 30 min. The neurobiological process of memory consolidation extends well beyond these time intervals, however, raising the possibility that these tests might not be fully sensitive to the subtle neurocognitive changes found in early disease or age-related decline. We aimed to determine the sensitivity of a 1-week delayed recall paradigm to medial temporal lobe (MTL) structure among neurologically normal older adults...
August 31, 2017: Clinical Neuropsychologist
Kasper Jørgensen, Peter Johannsen, Asmus Vogel
OBJECTIVE: The purpose of the present study was to develop a Danish adaptation of the Boston Naming Test (BNT) including a shortened 30-item version of the BNT for routine clinical use and two parallel 15-item versions for screening purposes. METHOD: The Danish adaptation of the BNT was based on ranking of items according to difficulty in a sample of older non-patients (n = 99). By selecting those items with the largest discrepancy in difficulty for non-patients compared to a mild Alzheimer's disease (AD) sample (n = 53), the shortened versions of the BNT were developed...
August 30, 2017: Clinical Neuropsychologist
Angelle M Sander, Allison N Clark, Laura M van Veldhoven, Robin Hanks, Tessa Hart, Luis Leon Novelo, Esther Ngan, David B Arciniegas
OBJECTIVES: To investigate the factor structure of the Everyday Memory Questionnaire (EMQ) in persons with traumatic brain injury (TBI). METHOD: This was a secondary analysis of baseline data from two clinical trials targeting memory impairment after TBI. Participants were 169 persons with complicated mild, moderate, or severe TBI at an average of 41 months post-injury. They completed the EMQ via clinical interview. Exploratory factor analysis was conducted using a three-factor principal axis factoring estimation method with a polychoric correlation matrix and oblique rotation...
August 29, 2017: Clinical Neuropsychologist
Andrea S Vincent, Tresa M Roebuck-Spencer, Eugenia Fuenzalida, Kirby Gilliland
OBJECTIVE: As the use of computer-based neurocognitive assessment is rapidly expanding, the need to systematically study and document key psychometric properties of these measures has become increasingly more salient. To meet this aim, this study examined test-retest reliability and practice effects for the Automated Neuropsychological Assessment Metrics General Neuropsychological Screening battery (ANAM GNS) in a sample of 94 community dwelling adults. METHOD: ANAM GNS was administered and then repeated (alternate form) after 30 days...
August 23, 2017: Clinical Neuropsychologist
Paul A Arbisi
A reflection on the exchange between Larrabee et al. (2017) and Nichols (2017) is provided by a clinical psychologist who co-authored an early critique questioning the validity of the FBS as a measure of over reporting and who, based on subsequent studies demonstrating the effectiveness of the FBS in identifying non-credible report of somatic and cognitive complaints, changed his opinion regarding the utility of the FBS/FBS-r as a symptom validity measure. Given the accumulated evidence demonstrating the effectiveness of the FBS/FBS-r as a symptom validity measure, reasons for the continued debate over the validity and utility of the FBS/FBS-r are discussed...
August 22, 2017: Clinical Neuropsychologist
April Au, Susan Vandermorris, Peter G Rendell, Fergus I M Craik, Angela K Troyer
OBJECTIVE: Prospective memory is the ability to 'remember to remember' and a facet of memory important to everyday functioning. For older adults, prospective memory slips are a common concern. In the present study, we conducted an initial validation of a paper-and-pencil adaptation of the Actual Week test, and reported on internal consistency, inter-rater and test-retest reliability, convergent and divergent validity, as well as veridicality of the task. METHOD: Fifty-eight healthy, community-dwelling older adults were recruited from a larger randomized controlled trial and tested at baseline...
August 22, 2017: Clinical Neuropsychologist
Glenn J Larrabee, Kevin J Bianchini, Kyle B Boone, Martin L Rohling
OBJECTIVES: To address (1) Whether there is empirical evidence for the contention of Nichols and Gass that the MMPI-2/MMPI-2-RF FBS/FBS-r Symptom Validity Scale is a measure of Litigation Response Syndrome (LRS), representing a credible set of responses and reactions of claimants to the experience of being in litigation, rather than a measure of non-credible symptom report, as the scale is typically used; and (2) to address their stated concerns about the validity of FBS/FBS-r meta-analytic results, and the risk of false positive elevations in persons with bona-fide medical conditions...
August 22, 2017: Clinical Neuropsychologist
Jonathan M Grabyan, Robert L Collins, W Alexander Alverson, David K Chen
OBJECTIVE: Performance validity testing is an increasingly vital component of neuropsychological evaluation, though administration of stand-alone performance validity tests (PVTs) can be time-consuming. As the Test of Memory Malingering (TOMM) is among the most commonly used and researched PVTs, much work has focused on creating abbreviated versions while preserving diagnostic accuracy. A recent addition to this effort, errors on the first 10 items of Trial 1 (TOMMe10), was analyzed for its utility in predicting TOMM performance...
August 22, 2017: Clinical Neuropsychologist
James H Smith-Spark
OBJECTIVE: The effects of developmental dyslexia are not restricted solely to the processes involved in reading and spelling. Despite this broader impact on cognition, there has been very little dyslexia-related research on prospective memory (PM; memory for delayed intentions) until very recently. This paper focuses on reviewing a recent program of research which sought to explore this memory system in adults with dyslexia. METHOD: The review focuses mainly on studies of adults with dyslexia in which PM was compared with that of IQ-matched adults without dyslexia across clinical measures, computerized tests, self-report questionnaire, and more naturalistic tasks...
August 22, 2017: Clinical Neuropsychologist
Robert N Davis
No abstract text is available yet for this article.
August 14, 2017: Clinical Neuropsychologist
Isabelle Rouleau, Emmanuelle Dagenais, Alexandra Tremblay, Mélanie Demers, Élaine Roger, Céline Jobin, Pierre Duquette
OBJECTIVE: Multiple sclerosis (MS) is a progressive disease of the central nervous system affecting information processing speed, episodic memory, attention, and executive functions. MS patients also often report prospective memory (PM) failures that directly impact their functional autonomy, including professional and social life. The purpose of this paper was to review the literature concerning the assessment and remediation of PM deficits in MS. METHOD: The literature pertaining to PM impairment in MS was carefully reviewed using PubMed, PsyINFO, and Google Scholar, as well as cross-references from the articles published on this topic...
August 4, 2017: Clinical Neuropsychologist
Phillip K Martin, Ryan W Schroeder, Lyle E Baade
OBJECTIVE: Normative sample composition can vary notably as a function of exclusionary criteria in older adult samples given that typical medical conditions of exclusion become more prevalent with age. Older adult norms may consist of typically aging or healthy aging individuals according to the stringency of the exclusion criteria, a difference illustrated when comparing two normative samples for the RBANS: the original standardization sample and the Oklahoma sample. METHODS: The current study examined the clinical impact of norm selection in older adults by analyzing impairment classification rates for 105 older adult behavioral health inpatients...
July 28, 2017: Clinical Neuropsychologist
Graeme Senior, Adina Piovesana, Patricia Beaumont
OBJECTIVE: Discrepancy analyses refer to comparison methods that evaluate the relationship or differences between two measures in the same individual. A common type of discrepancy analysis involves the comparison of two trials within a measure, such as, Trails A and B of the Trail Making Test (TMT). The TMT is well-suited to this role as the two measures are highly correlated, assess similar underlying constructs, and most importantly demonstrate differential vulnerability to the impact of pathology...
July 28, 2017: Clinical Neuropsychologist
Alessio Toraldo, Cristian Romaniello, Paolo Sommaruga
OBJECTIVE: Unilateral neglect is usually investigated by adminstering stimuli (targets) in different positions, with targets being responded to by the patient (Hit) or omitted. In spite of this homogeneity of data type, neglect indices and diagnostic criteria vary considerably, causing inconsistencies in both clinical and experimental settings. We aimed at deriving a standard analysis which would apply to all tasks sharing this data form. METHODS: A-priori theoretical reasoning demonstrated that the mean position of Hits in space (MPH) is an optimal index for correctly diagnosing and quantifying neglect...
July 25, 2017: Clinical Neuropsychologist
Marjolein J A M van Dijk, Tom Claassen, Christiany Suwartono, William M van der Veld, Paul T van der Heijden, Marc P H Hendriks
OBJECTIVE: Since the publication of the WAIS-IV in the U.S. in 2008, efforts have been made to explore the structural validity by applying factor analysis to various samples. This study aims to achieve a more fine-grained understanding of the structure of the Dutch language version of the WAIS-IV (WAIS-IV-NL) by applying an alternative analysis based on causal modeling in addition to confirmatory factor analysis (CFA). The Bayesian Constraint-based Causal Discovery (BCCD) algorithm learns underlying network structures directly from data and assesses more complex structures than is possible with factor analysis...
July 20, 2017: Clinical Neuropsychologist
A Smerbeck, Ralph H B Benedict, Arman Eshaghi, Sandra Vanotti, Carina Spedo, Jana Blahova Dusankova, Mohammad Ali Sahraian, Vanessa D Marques, Dawn Langdon
OBJECTIVE: In answer to the call for improved accessibility of neuropsychological services to the international community, the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS; MS) was validated in multiple, non-English-speaking countries. It was created to monitor processing speed and learning in MS patients, including abbreviated versions of the Symbol Digit Modalities Test, California Verbal Learning Test, 2nd Edition, and the Brief Visuospatial Memory Test, Revised...
July 19, 2017: Clinical Neuropsychologist
Jacqueline N Zadelaar, Joost A Agelink van Rentergem, Hilde M Huizenga
OBJECTIVE: Normative comparison is a method to compare an individual to a norm group. It is commonly used in neuropsychological assessment to determine if a patient's cognitive capacities deviate from those of a healthy population. Neuropsychological assessment often involves multiple testing, which might increase the familywise error rate (FWER). Recently, several correction methods have been proposed to reduce the FWER. However these methods require that multivariate normative data are available, which is often not the case...
July 5, 2017: Clinical Neuropsychologist
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"